Nutrigenomics: Personalizing Weight Loss for Obese Veterans
NCT01859403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2021-04-13
Summary
This study aims to determine if providing genomic information to veterans can help them lose weight compared to usual care.
Conditions
Interventions
- GENETIC
-
Personalized Genomics
A set of single nucleotide polymorphisms in genes important for obesity, eating behaviors and exercise
- GENETIC
-
Usual Care
Patients receive the same dietary recommendation regardless of their genetic information
Sponsors & Collaborators
-
University of California, San Diego
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-12-31
- Completion
- 2014-03-31
Countries
- United States
Study Locations
More Related Trials
-
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
NCT00479492 ·Status: COMPLETED ·Phase: PHASE2
-
An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)
NCT00131430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesity
NCT06380426 ·Status: RECRUITING
-
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
NCT05564117 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
NCT05579249 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
NCT06500429 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Semaglutide on Body Composition and Performance in Military Personnel
NCT06468748 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
NCT06041217 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
NCT00622765 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
NCT03548987 ·Status: COMPLETED ·Phase: PHASE3
-
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
NCT05035095 ·Status: COMPLETED ·Phase: PHASE3
-
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
NCT00092859 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
NCT06390501 ·Status: COMPLETED ·Phase: NA
-
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
NCT03600480 ·Status: COMPLETED ·Phase: PHASE1
-
Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
NCT03799198 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment
NCT07194317 ·Status: COMPLETED ·Phase: NA
-
Semaglutide Use in Elderly Obese Patients
NCT05302596 ·Status: COMPLETED ·Phase: PHASE2
-
Semaglutide's Weight Loss Effects in Obesity
NCT06825793 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
NCT04251156 ·Status: COMPLETED ·Phase: PHASE3
-
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World
NCT06874751 ·Status: COMPLETED
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity
NCT00231608 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
NCT02870231 ·Status: COMPLETED ·Phase: PHASE1